Similarly, TRiC subunits CCT2, CCT3, CCT4, CCT5, CCT7 and TCP1, were measured in higher levels in the plasma of GBM patients relative to healthy controls, with significant increases in CCT2 and CCT7 [5]. This evidence concerns the gene CCT2 and glioblastoma.